Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Single-centre, Feasibility Study to Evaluate the Use of 18F-PSMA PET/CT in Patients With Biochemically Active Medullary Thyroid Cancer

NCT05534594 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT05534594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05534594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Single-centre, Feasibility Study to Evaluate the Use of 18F-PSMA PET/CT in Patients With Biochemically Active Medullary Thyroid Cancer
Lead sponsor
University Medical Center Groningen
Phase
Not applicable
Overall status
Completed
Start date
August 19, 2022
Completion date
December 31, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medullary thyroid cancer, medullary thyroid carcinoma, thyroid cancer, medullary, thyroid carcinoma, medullary